The platform for open scholarly exchange and collaboration.

Home » ncRNA-Cancer » Session S2: Translational Applications of ncRNAs as Biomarkers

2nd International Symposium on Frontiers in Molecular Science
Non-Coding RNAs and Epigenetics in Cancer

S2: Translational Applications of ncRNAs as Biomarkers

List of Accepted Abstracts (17)
RNA Editing and Melanoma Metastasis
Upregulated lncRNA-HNGA1, a Target of miR-378a, Contributes to Aerobic Glycolysis of Head and Neck Squamous Cell Carcinoma Throughincreasing Levels of the C-C Chemokine Receptor Type 7 (CCR7)
A Specific Long Non-Coding RNA Expression Signature Defines the Philadelphia-like B-Cell Acute Lymphoblastic Leukemia Subtype
Differentially Expressed lncRNA Transcripts in Clinical Subtypes of Breast Carcinoma
Epigenetic Biomarkers of Prognosis in Stage IIA Colon Cancer
Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
High-Risk Plasma microRNA Signature Is Associated with an Immune-Related Gene Expression Profile of Lung Tumour Tissues
Hybridized Meta-Heuristic for Range-Based Node Localization in an Outdoor Wireless Sensor Network
Long noncoding RNA PVT1 as Promising Biomarker for Colorectal Adenocarcinoma
Long-Non Coding RNA Deregulation in Non-Small Cell Lung Cancer
MicroRNA Dysregulation to Identify Therapeutic Target Combinations for Chronic Lymphocytic Leukemia
miRNAs Modulating Melanoma Cell Invasion
Noncoding RNA Function and Regulation in Animal Development
Plasma Viral miRNAs as Targeted-biomarkers of Occult Viral Infections Prevalence and Sepsis Aggressiveness
Potential Role of non-coding RNA in Hepatocellular Carcinoma Revealed by Whole Exome Sequencing
Role of Exosomal miRNAs in the Biology of the Tumor Microenvironment
Stepwise Analysis of MIR9 Loci Identifies miR-9-5p to be Involved in Oestrogen Regulated Pathways in Breast Cancer Patients